CA
HALO icon

CoreCap Advisors’s Halozyme HALO Stock Holding History

CoreCap Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Buy
153
+149
+3,725% +$10.2K ﹤0.01% 2000
2026
Q1 		$259 Sell
4
-366
-99% -$25.8K ﹤0.01% 2738
2025
Q4 		$24.9K Sell
370
-5,481
-94% -$369K ﹤0.01% 1590
2025
Q3 		$429K Buy
+5,851
New +$389K 0.02% 559
2025
Q1 		– Sell
-15,831
Closed -$757K – 3208
2024
Q4 		$757K Buy
15,831
+4,242
+37% +$218K 0.03% 376
2024
Q3 		$663K Buy
+11,589
New +$664K 0.03% 403

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

CoreCap Advisors's HALO Position: Q2 2026 in Review

CoreCap Advisors increased its Halozyme (HALO) stake by 3,725% in Q2 2026, buying an estimated $10.2K and bringing the position to 153 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #2000.

CoreCap Advisors first reported a position in HALO in Q3 2024 and has held it in 6 quarters since. The position peaked at $757K in Q4 2024. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • CoreCap Advisors held 153 shares of Halozyme worth $12K as of Q2 2026.
  • CoreCap Advisors bought 149 Halozyme shares in Q2 2026, an estimated $10.2K.
  • Halozyme made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2000 holding.
  • CoreCap Advisors first reported a position in Halozyme in Q3 2024 and has held it in 6 quarters since.
  • CoreCap Advisors's Halozyme position peaked at $757K in Q4 2024.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.